Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-04

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Co-administration of AD-227A and AD-227B [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of co-administration of AD-227A and AD-227B for essential hypertension and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AD-227A
  • AD-227B

Snippet

Sponsor: Addpharma Inc. | Conditions: Essential Hypertension | Phase 3 | Status: RECRUITING